What should patients know about treatment with rituximab for ANCA vasculitis? What do physicians consider when starting a patient on this medication? Dr. Patrick Nachman and Dr. Ron Falk explain these details in a new episode of Chair’s Corner. Dr. Patrick Nachman is the Covington Distinguished Professor of Medicine in the Division of Nephrology and Hypertension at UNC, and he also serves as the Deputy Director for the UNC Kidney Center.

A better understanding of HIV latency is the key to eradicating the virus researchers at the University of North Carolina and partner institutions write in a perspective in the journal Science.

In each e-newsletter we plan to highlight one of our outstanding clinical programs. This summer we are highlighting the Center for Esophageal Diseases and Swallowing (CEDAS).

In each e-newsletter we plan to profile research being done by one of our 40+ faculty members. This summer we are highlighting Dr. Millie Long from our IBD program.

Anti-HIV medications suppress the viral load of people living with HIV and provide durable protection against heterosexual transmission, a study led by the University of North Carolina at Chapel Hill found. Researchers found a 93 percent reduction of HIV transmission when the HIV-infected person started antiretroviral therapy or ART at a higher CD4 cell count. The groundbreaking final results of the HIV Prevention Trials Network (HPTN) 052 study were published in the New England Journal of Medicine.

The UNC Center for Bronchiectasis Care recently opened in Meadowmont in Chapel Hill, NC. In this new Chair’s Corner podcast, Dr. Ron Falk interviews Dr. Peadar Noone, who is a Professor of Medicine in the Division of Pulmonary & Critical Care Medicine, and Medical Director for this new center. Dr. Noone answers some questions patients commonly ask about bronchiectasis and mycobacterial lung infections.

UNC School of Medicine faculty members Miranda van Tilburg, PhD and William Whitehead, PhD took on critical roles in amending diagnostic criteria questionnaires for the Rome Foundation, an international nonprofit aimed at improving the lives of the millions of people suffering from functional GI disorders (FGIDs).

Dr. Carson, Professor of Medicine and Division Chief of Pulmonary Diseases and Critical Care Medicine, along with co-principal investigator Judith Nelson, MD, JD, at Memorial Sloan Kettering Cancer Center, and Christopher Cox, MD, of Duke University, led a four-year, first-of-its kind clinical study.

The UNC School of Medicine selected Karen Mohlke, PhD, professor of genetics, and Victor Garcia-Martinez, PhD, professor of medicine and member of the UNC Institute for Global Health and Infectious Diseases, as Smithies Investigators, an annual award to honor senior faculty members who have made significant research contributions and achieved international recognition for their work.

  Jenny Flythe, MD, MPH Jenny Flythe, MD, MPH Dr. Flythe is a nephrologist and clinical investigator focused on improving clinical outcomes and quality of life for individuals with dialysis-dependent end-stage kidney disease. She joined the UNC School of Medicine faculty in 2014 after completing her nephrology fellowship and public health training at Brigham and … Read more

UNC School of Medicine faculty members took on critical roles in amending diagnostic criteria questionnaires for functional GI disorders, which affect millions of people worldwide.